SR One is a transatlantic biotechnology venture capital firm that partners with founders to translate innovative science into medicines. It focuses on companies with strong fundamentals, clear development pathways, and novel approaches to addressing diseases, leveraging its presence in the US and UK to provide strategic support.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
United KingdomUnited States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
54.5%United Kingdom
15.9%Switzerland
4.5%Brazil
2.3%Canada
2.3%Other
9.2%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
No stages listed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund I
Vintage 2020 • $500M
Fund II
Vintage 2023 • $600M